£77.60

It has never been this cheap. We have no record of a lower price.

£78 today · cheaper than every other day in the last 3 months

Imperial College Press ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (MOLECULAR MEDICINE AND MEDICINAL CHEMISTRY)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 46 days · 46 data points (no recent data)

Historical
Generating forecast…
£78.99 £77.46 £77.79 £78.13 £78.46 £78.80 £79.13 25 July 2026 05 August 2026 16 August 2026 27 August 2026 08 September 2026
View at Amazon ↗

Price data last checked 45 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 46 days • 2 price levels

Days at Price
Current Price
15 days · current 31 days 0 8 16 23 31 £78 £79 Days at Price

Price Analysis

Most common price: £79 (31 days, 67.4%)

Price range: £78 - £79

Price levels: 2 different prices over 46 days

Description
Alzheimer's disease is the most common form of senile dementia, affecting more than 24 million people worldwide. It is characterised pathologically by abnormally high levels of neurofibrillary tangles resulting from the accumulation of tau protein in dead and dying neurons, and by elevated numbers of senile plaques in the cortex and hippocampus of the brain. The major component of senile plaques is a small protein of 39-43 amino acids called amyloid-β (Aβ). Thus far, no treatment has been shown to slow the progression of sporadic and familial Alzheimer's disease.A large body of evidence points, however, to the early Aβ-formed oligomers as the primary toxic species in Alzheimer's disease. A powerful strategy for developing pharmaceutical treatments against Alzheimer's is to elucidate the pathways of oligomer formation and determine the structures of the toxic aggregates.This book provides a panoramic view across recent in vitro and in vivo studies along with state-of-the-art computer simulations, designed to increase the readers' understanding of Aβ oligomerisation and fibril formation. At the same time, the book delves into the pathogenesis of familial and sporadic Alzheimer's disease at the atomic level of detail.Written by leading authors in their respective fields, this book will be valuable to all scientists working on Alzheimer's disease.

Product Specifications
Brand
Imperial College Press
Format
hardcover
ASIN
1848167547
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain
Amazon UK
Release Date
28 February 2013
Listed Since
10 February 2011

Barcode

No barcode data available

Similar Products You Might Like

Alzheimer's Disease: Biology, Biophysics And Computational Models
97% match

Alzheimer's Disease: Biology, Biophysics And Computational Models

World Scientific Publishing Company

£90.68 08 Sep 2026
Biomarkers for Early Diagnosis of Alzheimer's Disease
97% match

Biomarkers for Early Diagnosis of Alzheimer's Disease

£58.28 25 Sep 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
97% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£122.62 24 Sep 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
97% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£12.97 18 Sep 2026
The End of Alzheimer's: The Brain and Beyond
96% match

The End of Alzheimer's: The Brain and Beyond

Elsevier

£50.89 21 Sep 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
96% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.82 24 Sep 2026
Alzheimer's Disease in the Middle-Aged
96% match

Alzheimer's Disease in the Middle-Aged

Brand: Nova Science Publishers

£105.18 25 Sep 2026
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
96% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£69.07 12 Sep 2026
Neuroprotection in Alzheimer's Disease
96% match

Neuroprotection in Alzheimer's Disease

Elsevier

£90.99 25 Sep 2026
Topics in Alzheimer's Disease
96% match

Topics in Alzheimer's Disease

£105.67 24 Sep 2026
Trends in Alzheimer's Disease Research
96% match

Trends in Alzheimer's Disease Research

£40.91 24 Sep 2026
Alzheimer's Diagnosis (Neuroscience Research Progress)
96% match

Alzheimer's Diagnosis (Neuroscience Research Progress)

£95.59 08 Sep 2026
New Research on Alzheimer's Disease
96% match

New Research on Alzheimer's Disease

£99.70 24 Sep 2026
Frontiers in Alzheimer's Disease Research
96% match

Frontiers in Alzheimer's Disease Research

£43.78 24 Sep 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
96% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Elsevier

£114.89 11 Sep 2026
Leading-Edge Research in Alzheimer's Disease
96% match

Leading-Edge Research in Alzheimer's Disease

£30.69 24 Sep 2026
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
96% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£83.20 18 Sep 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
96% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£154.94 04 Sep 2026
Intracellular Consequences of Amyloid in Alzheimer's Disease
96% match

Intracellular Consequences of Amyloid in Alzheimer's Disease

Academic Press

£47.99 02 Oct 2026
Clinical Diagnosis and Management of Alzheimer's Disease
96% match

Clinical Diagnosis and Management of Alzheimer's Disease

CRC Press

£151.26 28 Aug 2026